Job Title - SVP, Integrated Early Development & Clinical Solutions
Work Location - Remote
Summary:
Integrated Early Development & Clinical Solutions will establish and lead an agile early-stage asset acceleration capability, serving as the primary strategic partner for WuXi’s expanding global client network—spanning emerging biotechs to multinational pharma companies.
This turnkey capability seamlessly bridges global client strategy with China’s high-speed, cost-advantaged biopharma ecosystem. Leveraging WuXi’s proprietary technology platforms, the role drives translational strategy and program alignment to guide client molecules from candidate nomination through integrated early-phase CMC, IND enablement, and early clinical trials to key value-inflection points, including First-in-Human (FIH) and Proof-of-Concept (PoC).
Responsibilities
- Strategic Global Partnering: Build a high-velocity early-development advisory and execution model offering tailored, flexible engagement frameworks for partners ranging from VC-backed biotechs to multinational pharma. Serve as the senior executive sponsor for global clients and investors, driving cross-functional governance to enable partners to hit critical value-creation milestones faster.
- Integrated Early-Stage Asset Development: Define and govern end-to-end development plans (Discovery Integration, Translational Safety/Tox, Regulatory Strategy, and Early Clinical Operations) while providing overarching strategic direction to WuXi’s dedicated CMC execution teams.
- Maximize China Ecosystem Synergy: Identify, architect, and scale models that seamlessly integrate WuXi’s robust CMC infrastructure with China’s broader CRO ecosystem and clinical trial capabilities to maximize capital efficiency, accelerate client timelines, and drive sustained company growth.
Qualifications
- 15+ Years of Leadership Experience: Biopharma executive with a proven track record of steering biotherapeutic programs from candidate nomination to Phase 1/2 clinical PoC.
- Strategic & Scientific Mastery: Deep expertise in novel biologics modalities (e.g., mAbs, bispecifics, ADCs, T-cell engagers), translational medicine, and global IND/CTA filings, backed by a strong high-level understanding of CMC milestones.
- Global Executive Stature: cross-cultural agility to connect global client vision with China-based operational teams
The job description does not intend to list all the duties and responsibilities assigned to this position. An employee holding this position would be required to perform other job-related duties/responsibilities based on their expertise and the company's business needs.
Biopharma executive with 15+ years of leadership experience steering biotherapeutic programs through Phase 1/2 proof of concept, expertise in biologics, translational medicine, IND/CTA filings, and CMC milestones.
Key Responsibilities
- sponsoring clients
- governing development
- integrating ecosystems
Skills & Tools
CMC, First-in-Human (FIH), Proof-of-Concept (PoC), IND, CTA, mAbs, ADCs
Job Details
- Category: Healthcare Services - Advanced Practice
- Seniority: Senior Level
- Commitment: Full Time
- Workplace: Remote — United States
- Languages: English
About WuXi Biologics
A biopharmaceutical services company providing integrated development and clinical capabilities for global clients. — Industry: Healthcare